HEM Hemosense

HemoSense, Inc. (AMEX:HEM) today announced that Jim Merselis, President and CEO, will make an investment community presentation at the 2007 FBR Growth Conference on Thursday, May 31, at 2:20 p.m. Eastern time (11:20 a.m. Pacific time). The conference is being held at the Grand Hyatt Hotel in New York City. A live audio and slide webcast of the presentation will be available via the Internet by visiting the Investors section of the Company�s Web site at www.hemosense.com. An archived presentation will be available on the Web site for 30 days. About HemoSense HemoSense is a point-of-care diagnostic healthcare company that develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio� system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient�s warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com. HemoSense� and INRatio� are registered trademarks of HemoSense, Inc.